Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Korosho to Train Senior CRCs, Data Managers, IRB Members
September 10, 2007
- Korosho to Demand \22,160.4 Bil., Up 3.2%, in FY2008
September 10, 2007
- Korosho to Standardize Forms for Clinical Trial Documents
September 10, 2007
- Japan's 1st Drug for ADHD Recommended for Approval
September 10, 2007
- R&D NEWS IN BRIEF
September 10, 2007
- REGULATORY NEWS IN BRIEF
September 3, 2007
- Korosho to Create Council for Promotion of Generics in Each Prefecture
September 3, 2007
- JMA to Survey Medical Professionals' Views on Quality of Generics
September 3, 2007
- Discussions Start for Revision of Ethical GL for Clinical Research
September 3, 2007
- SELF-MEDICATION NEWS IN BRIEF
September 3, 2007
- R&D NEWS IN BRIEF
September 3, 2007
- Daiichi Sankyo Ties Up with Forest Lab. for AZOR
September 3, 2007
- Japan Tissue Engineering's Autologous Epidermis Recommended for Approval
September 3, 2007
- Teijin to Codevelop Ipsen's ITM-077 with Chugai
September 3, 2007
- MEDICAL DEVICE NEWS IN BRIEF
September 3, 2007
- Peptisyntha to Expand Contract Peptide Manufacturing Business in Japan
September 3, 2007
- Drugs Account for 21.7% of Medial Expenditure
September 3, 2007
- DSP to Increase Its MRs' Scientific Knowledge
September 3, 2007
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
September 3, 2007
- Wholesalers' Operating Profit Ratio Exceeds 1% for the 1st Time in 8 Years
September 3, 2007
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…